NSRT to start Phase II trial of Eflornithine granules to treat COVID-19 by early Jan 2021
The company aims to complete the study by March 2021
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Navin Saxena Research & Technology
NSRT to conduct phase II trials of Eflornithine to treat COVID-19
The trials will be conducted in four cities namely; Delhi, Lucknow, Pune, and Bengaluru and the company aims to complete the…